BP000997-GD23: Recombinant Human Beta-Nerve Growth Factor (β-NGF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells was less than1.0 ng/ml. Corresponding to a specific activity of > 1 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).C040P: Alemtuzumab Biosimilar, CD52 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody alemtuzumab biosimilar specifically binds to the human CD52, a protein present on the surface of mature lymphocytes.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by alemtuzumab.